Table 2.
Comparison between studied thalassemia patients and healthy control.
| Variable | Control (n=20) | Thalassemia (n=40) | p-value |
|---|---|---|---|
| Gender (M/F) | 11/9 | 23/17 | 1.000¶ |
| Age (years) | 25 (21 – 28) | 21 (20–26) | .0800§ |
| SGPT (IU/l) | 32 (26 – 40) | 52 (31–76) | .008§ |
| SGOT (IU/l) | 30 (23 – 38) | 51 (31–73) | .004§ |
| Urea (mg/dL) | 25.5 (20.5 29.0) | 26.0 (22.0–29.0) | .620§ |
| Creatinine (mg/mL) | 0.7 (0.5 – 0.8) | 0.7 (0.6–0.8) | .173§ |
| Hemoglobin (g/dl) | 13.1 (12.0 – 13.9) | 6.7 (5.5–7.9) | <.001§ |
| WBCs (x1000/mm3) | 5.69 (5.35 – 7.80) | 9.10 (6.60–13.65) | .002§ |
| Platelets (x1000/ml3) | 266 (213 – 298) | 449 (303–720) | <.001¶ |
| vWFa (IU/dL) | 0.89 (0.61 – 1.40) | 3.98 (1.65–6.00) | <.001¶ |
| CD14 (μg/mL) | 5.43 (4.04 – 7.58) | 4.80 (2.82–6.77) | .204¶ |